1. Home
  2. VIPS vs BLLN Comparison

VIPS vs BLLN Comparison

Compare VIPS & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vipshop Holdings Limited

VIPS

Vipshop Holdings Limited

HOLD

Current Price

$15.25

Market Cap

6.7B

ML Signal

HOLD

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

HOLD

Current Price

$136.55

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIPS
BLLN
Founded
2008
2016
Country
China
United States
Employees
N/A
713
Industry
Catalog/Specialty Distribution
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
5.8B
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
VIPS
BLLN
Price
$15.25
$136.55
Analyst Decision
Buy
Buy
Analyst Count
4
7
Target Price
$19.58
$126.71
AVG Volume (30 Days)
1.9M
593.0K
Earning Date
05-19-2026
05-06-2026
Dividend Yield
4.38%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.79
$46.29
Revenue Next Year
$2.05
$30.14
P/E Ratio
$9.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.65
$61.96
52 Week High
$21.08
$139.79

Technical Indicators

Market Signals
Indicator
VIPS
BLLN
Relative Strength Index (RSI) 69.23 63.32
Support Level $14.78 $79.07
Resistance Level $15.87 $138.70
Average True Range (ATR) 0.37 7.53
MACD 0.10 -0.04
Stochastic Oscillator 98.05 81.68

Price Performance

Historical Comparison
VIPS
BLLN

About VIPS Vipshop Holdings Limited

Vipshop is a leading Chinese online discount retailer offering branded products at attractive discounts of 10%-90% off their original price through daily flash sales. It operates warehousing, retailing, product procurement, software development, and information technology support in-house while outsourcing to third-party logistics providers for distribution and shipments. Branded products on Vipshop's platform are sourced mostly through a consignment model with global brand partners. As of March 31, 2025, Eric Ya Shen, chair and CEO, had 64.5% voting rights. Leading Chinese social media firm and strategic shareholder Tencent also holds a 12.5% interest.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: